0SZI trade ideas
$CRBP bull traction.CRBP looks like it's gaining a lot of positive attraction breaking previous sideways support and resistance.
Needs to break resistance @$2.55 and create a support to gain confidence for the bulls to drive up to pre-covid.
Do your own research as always but I'll be putting an order in @2.55 with a stop loss of 10% of that.
Open to thoughts and opinions on this company and it's future predictions.
Corbus Pharma gap fill buy opportunityBuy at market with 0,95 stop loss and target of 9. if it closes on weekly above 9,8 then the sky is the limit.
$CRBP Dead Cat BounceCorbus Pharmaceuticals Holdings, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. Its lead product candidate is lenabasum, a synthetic oral endocannabinoid drug that is in Phase III clinical trials for the treatment of systemic sclerosis and dermatomyositis, and in Phase IIb clinical trials to treat systemic lupus erythematosus and cystic fibrosis. The company is also developing CRB-4001, a peripherally-restricted CB1 inverse agonist, for nonalcoholic steatohepatitis and other fibrotic diseases. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, which includes the Jenrin library of approximately 600 compounds and multiple issued and pending patent filings; and strategic collaboration with Kaken Pharmaceutical Co., Ltd. for the development and commercialization of lenabasum in Japan. The company was founded in 2009 and is based in Norwood, Massachusetts.
CRBP vs Sector
CRBT Unusual move. Not in positions until . HI traders .
Lots of speculations on this one .
Will watch closely 18Th and wait until we reach that date . This could be good play for next week , Trading brake out on it only ,
Corbus Pharmaceuticals $CRBP - investment idea 💡 This entry and SL is based on my technical analysis only.
Do your research and trade on your own risk!
$CRPB Corbus Pharma $2.00 target Corbus Pharmaceuticals Holdings, Inc. is a phase 3 clinical-stage pharmaceutical company, which focuses on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus. The company was founded on December 18, 2013 and is headquartered in Norwood, MA.
CRBP - Long Setup Watch for a break of 1.29, Stop signal 1.14. First target 1.66. Second target momentum. If open range were bullish i would look for a lower entry yet things are still 50/50 until we get that signal.
CorbusCorbus
1.Price held to support and did not break 61.8% retracement level
from the bottom
2. A push to 1.30 and retracement to confirm the long entry
3. Will be in my watchlist for the coming week
CRBP TRADING AT A DEAL This company sold off because they said they were cutting 54% of their workers to help with cash flow into 2022 during the coronavirus pandemic. The market has clearly priced that in, and I honestly think it's long term bullish! Less employees: less people to pay out! CRBP has a lot of potential upside (more than likely not anytime soon), however, they have the 1st potential systematic sclerosis therapy that is looking to receive FDA approval some time around 2021 . Estimated revenue projections for the therapy, which would meet a need created by 320,000 patients worldwide if/when approved, are at 8 billion dollars. With only phase 2 data CRBP was able to get a deal from japan to close a deal for 27M (about 37,000 patients there). CRBP says they are trying to get the EU, and the rest of the globe for that matter, on board; If the EU was to grant a deal similar to Japans deal (made in 2018 btw), they could receive 233 million for that deal. All of this data is from a seeking alpha article; at 7 dollars they said the company has 2x upside from there. In all honesty I suspect to see a buyout in about 6 months or so... just a feeling; this stock is giving me an 'AIMT' vibe.
GL!
EQUITY LONG : CRBP CONTINUED - MACROSCALEJust a bit of the bigger picture on this cheap stock. Good luck folks.
EQUITY LONG : CRBPFDA phase 3 failure led to a massive dump.
As we know, every reaction in the market is an over-reaction, so get in while it is cheap, or wait and see.
Maybe selling puts here could be the correct action.
Best of luck.
Largo en Corbus Pharm. (CORRECIÓN)CORRECCIÓN DEL POST PUBLICADO AYER. Mal visto ayer el movimiento que está haciendo el precio aunque tampoco se descarta totalmente pero veo más posible una continuación de la tendencia alcista. Se puede ver como se ha formado un soporte y parece continuar la tendencia alcista.
CORBUS
Posible corto Corbus PharmaceuticalsEsperando correción del precio, MA 15 Y 50, osciladores neutros (MACD, RSI, RVGI)
Looking for a sizable advance in pot stocks - CRBP to outperformFirst I would like to start by saying that we are looking for a major bottom in pot stocks. Corbus Pharmaceuticals is one stock in the weed sector, which is already showing signs of a lasting low in place near 3.30 and overall leading to the upside along with Aurora and Apharia. The first piece of evidence is the upside break of the descending price channel that has contained the entire bear market since late 2016. Prices subsequently retested the upper side of the channel, which then acted as support to the latest drop. This is another positive sign for the bulls. We view this breakout as the early stages of a third-wave advance in Elliott terms. This implies sharply higher prices towards the Fibonacci cluster into the 18-19 area. Likely stopping point for prices in wave ((3)) are marked on the chart with the wave ((1)) high near 11 a major obstacle. Above there confirms the presence of wave ((3)) and adds upside traction.
Disclaimer: This is not trading advice! I am merely expressing my opinion, utilizing the Wave Principle as my main tool. You should always do your own research before risking your hard-earned money. The opinion expressed in this post is for educational purposes only!
